Antithrombotic therapy after percutanous coronary intervention with stenting;Antitrombotisk behandling etter perkutan koronar intervensjon med stent

Tidsskrift for den Norske Laegeforening

Volumn 128, Issue 4, 2008, Pages 436-439

  Vik Mo, Harald ^a,b   Slette, Morten ^a   Hegbom, Knut ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; FIBRINOLYTIC AGENT; TICLOPIDINE; WARFARIN;

DRUG ELUTING STENT; HEART INFARCTION; HUMAN; REVIEW; RISK FACTOR; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; DRUG-ELUTING STENTS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STENTS; TICLOPIDINE; TIME FACTORS; WARFARIN;

EID: 39749194419     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (30)